40 likes | 50 Views
The growing prevalence of chronic illnesses such as oncological illnesses, diabetes and cardiovascular and respiratory disorders has contributed to a worldwide rise in drug use.<br><br>Further, demand for the production of new drugs through comprehensive clinical trials has increased. Also, Pharmacovigilance is the inevitable part of the processes of drug discovery, safety and production.<br><br>Request Free Sample @ https://www.oganalysis.com/sample/216424<br><br>In addition, increase in occurrence of Adverse Drug Reactions (ADRs) to accelerate consumer demand for those services over the forecast period 2020-2026.<br><br>The emergence of a competitive framework for the drug introduction of new molecules often led to a strong demand for enhanced manufacturing processes, pharmacovigilance and others.<br><br>Browse Pharmacovigilance Market, Research Report @ https://www.oganalysis.com/industry-reports/216424/pharmacovigilance-market<br><br>Moreover, superior quality of care, medical decision-making, automated access and improved workflow and patient management to fuel the EHR mining segment.<br><br>Regional analysis of Pharmacovigilance Market share<br><br>North America holds the major market share owing to the presence of key players in the pharmaceutical and medical industries contributing to overall revenue in this region.<br><br>The increase in opioid misuse and related adverse drug reactions leads to morbidity and death, which serves as a high growth making driver for the North American market.<br><br>Further, increase in investments by major players for the inspection of novel drugs to enhance the regional market value. Correspondingly, the number of clinical trials and the need for post-marketing surveillance has increased as a result of the large production of drugs, thereby contributing to total growth.<br><br>Asia Pacific is set to grow a lucrative rate during the forecast period 2020-2026 attributed to the availability of various outsourcing organizations.<br><br>The major factors contributing for growth include improved productivity, cost efficiency, and resource sharing to propel the regional demand for pharmacovigilance in Asia Pacific market.<br><br>Request for Special Discount on Pharmacovigilance Market @ https://www.oganalysis.com/discount/216424<br><br><br>Contribution of prominent player to influence the pharmacovigilance market share<br><br>Collaboration, agreements and investments in R&D activities to trigger the pharmacovigilance market growth. For example, Oracle Health Sciences recently worked with one pharmaceutical company to bring efficiency to its pharmacovigilance programme.<br><br>Further, in 2020, Nextrove proclaimed an agreement to integrate Advera Healthu2019s Evidexu00ae to accelerate drug safety decisions through technology built specifically for modern pharmacovigilance analytics and signaling.<br><br>In addition, in 2020, the Indian Council of Medical Research permitted the prophylactic use of hydroxychloroquine to be coupled with the pharmacovigilance for adverse drug reactions.<br><br>Furthermore, in 2020, Ergomed PLC provided drug safety services through its specialist pharmacovigilance provider PrimeVigilance for an ongoing US clinical trial.<br><br>Additionally, in 2019, UCB collaborate with Accenture to work together on pharmacovigilance. Also, in 2019, a new pharmacovigilance document from the European Medicines Agency showed that the medicine safety system in the EU is effective.<br><br>Major key players of pharmacovigilance market include Accenture, Linical Accelovance, Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L; IQVIA, TAKE Solutions Ltd., PAREXEL International Corporation, BioClinica Inc., and Wipro Ltd. among others.<br><br>Related reports<br><br>u2022 Pharmaceutical Analytical Testing Market<br>u2022 Pharmaceutical Analytical Testing Outsourcing Market<br><br>Ambarish Ram<br>OG Analysis<br> 91 73370 13757<br>email @ sales@oganalysis.com
E N D
01/05/2020 Pharmacovigilance Market size with a 4.78% CAGR through 2026 ISSUED BY OG ANALYSIS Pharmacovigilance Market size with a 4.78% CAGR through 2026 Global Pharmacovigilance Market 2020 Pharmacovigilance Market Size, Share and Trend Analysis Report to 2026- Growth Opportunities and Competitive Analysis EGYPT, April 16, 2020 /EINPresswire.com/ -- The growing prevalence of chronic illnesses such as oncological illnesses, diabetes and cardiovascular and respiratory disorders has contributed to a worldwide rise in drug use. Further, demand for the production of new drugs through comprehensive clinical trials has increased. Also, Pharmacovigilance is the inevitable part of the processes of drug discovery, safety and production. Request Free Sample @ https://www.oganalysis.com/sample/216424 In addition, increase in occurrence of Adverse Drug Reactions (ADRs) to accelerate consumer demand for those services over the forecast period 2020-2026. The emergence of a competitive framework for the drug introduction of new molecules often led to a strong demand for enhanced manufacturing processes, pharmacovigilance and others. Browse Pharmacovigilance Market, Research Report @ https://www.oganalysis.com/industry- reports/216424/pharmacovigilance-market Moreover, superior quality of care, medical decision-making, automated access and improved workflow and patient management to fuel the EHR mining segment. Questions? +1 (202) 335-3939 Set Up FREE Account https://www.einpresswire.com/article/514748426/pharmacovigilance-market-size-with-a-4-78-cagr-through-2026 1/4
01/05/2020 Pharmacovigilance Market size with a 4.78% CAGR through 2026 Regional analysis of Pharmacovigilance Market share North America holds the major market share owing to the presence of key players in the pharmaceutical and medical industries contributing to overall revenue in this region. The increase in opioid misuse and related adverse drug reactions leads to morbidity and death, which serves as a high growth making driver for the North American market. Further, increase in investments by major players for the inspection of novel drugs to enhance the regional market value. Correspondingly, the number of clinical trials and the need for post-marketing surveillance has increased as a result of the large production of drugs, thereby contributing to total growth. Asia Pacific is set to grow a lucrative rate during the forecast period 2020-2026 attributed to the availability of various outsourcing organizations. The major factors contributing for growth include improved productivity, cost efficiency, and resource sharing to propel the regional demand for pharmacovigilance in Asia Pacific market. Request for Special Discount on Pharmacovigilance Market @ https://www.oganalysis.com/discount/216424 Contribution of prominent player to influence the pharmacovigilance market share Collaboration, agreements and investments in R&D activities to trigger the pharmacovigilance market growth. For example, Oracle Health Sciences recently worked with one pharmaceutical company to bring efficiency to its pharmacovigilance programme. Further, in 2020, Nextrove proclaimed an agreement to integrate Advera Health’s Evidex® to accelerate drug safety decisions through technology built specifically for modern pharmacovigilance analytics and signaling. In addition, in 2020, the Indian Council of Medical Research permitted the prophylactic use of hydroxychloroquine to be coupled with the pharmacovigilance for adverse drug reactions. Furthermore, in 2020, Ergomed PLC provided drug safety services through its specialist pharmacovigilance provider PrimeVigilance for an ongoing US clinical trial. Additionally, in 2019, UCB collaborate with Accenture to work together on pharmacovigilance. Also, in 2019, a new pharmacovigilance document from the European Medicines Agency showed that the medicine safety system in the EU is effective. Major key players of pharmacovigilance market include Accenture, Linical Accelovance, Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L; IQVIA, TAKE Solutions Ltd., PAREXEL International Corporation, BioClinica Inc., and Wipro Ltd. among others. Related reports • Pharmaceutical Analytical Testing Market • Pharmaceutical Analytical Testing Outsourcing Market Ambarish Ram OG Analysis +91 73370 13757 email us here Questions? +1 (202) 335-3939 Set Up FREE Account https://www.einpresswire.com/article/514748426/pharmacovigilance-market-size-with-a-4-78-cagr-through-2026 2/4
01/05/2020 Pharmacovigilance Market size with a 4.78% CAGR through 2026 Visit us on social media: Facebook Twitter LinkedIn Share on Facebook · Twitter · LinkedIn Distribution channels: Banking, Finance & Investment Industry, Business & Economy, Companies, Healthcare & Pharmaceuticals Industry, Retail EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors. Press Contact Share This Story Company Details Ambarish Ram OG Analysis +91 73370 13757 email us here Facebook Twitter LinkedIn Print PDF OG Analysis Lakshmi Sai Damam, Hi-Tech City Hyderabad, 500081 India +91 73370 13757 Visit Website Visit Newsroom About OG Analysis has been a trusted research partner for 10+ years delivering most reliable analysis, information and innovative solutions. OG Analysis is one of the leading players in market research industry serving 980+ companies across multiple industry verticals. Our core client centric approach comprehends client requirements and provides actionable insights that enable users to take informed decisions. Contact Us: Anil Kumar Phone: +91-7337 01 3757 Email: sales@oganalysis.com More From This Author Intravenous Immunoglobulin (IVIG) Market to grow with a CAGR of 7.2% over the forecast period 2020-2026 Biologics Market to emerge with a robust growth of 10.4% CAGR over 2020-2026 Animal Health Market to grow with a CAGR of 5.87% during the estimated time period 2020-2026 View All Stories From This Author Questions? +1 (202) 335-3939 Set Up FREE Account https://www.einpresswire.com/article/514748426/pharmacovigilance-market-size-with-a-4-78-cagr-through-2026 3/4
01/05/2020 Pharmacovigilance Market size with a 4.78% CAGR through 2026 Questions? +1 (202) 335-3939 Set Up FREE Account https://www.einpresswire.com/article/514748426/pharmacovigilance-market-size-with-a-4-78-cagr-through-2026 4/4